Last quarter (Q ), CERo Therapeutics Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, CERo Therapeutics Holdings's net income was $-282.76K. See CERo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21
Total Revenue	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Expense	$ 2.93M	$ 2.93M	$ 2.91M	$ 332.03K
Operating Income	$ -2.93M	$ -2.93M	$ -2.91M	$ -332.03K
Net Non Operating Interest Income Expense	$ 491.57K	$ 491.57K	-	-
Other Income Expense	-	-	$ 2.84M	$ -385.00
Pretax Income	$ -2.44M	$ -2.44M	$ -68.58K	$ -332.42K
Tax Provision	$ 94.82K	$ 94.82K	$ 599.16K	$ -16.87K
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -2.54M	$ -2.54M	$ -667.74K	$ -315.55K
Basic EPS	$ -0.78	$ -0.78	$ -0.03	$ -0.03
Diluted EPS	$ -0.78	$ -0.78	$ -0.03	$ -0.03
Basic Average Shares	$ 26.11M	$ 6.53M	$ 22.49M	$ 9.65M
Diluted Average Shares	$ 26.11M	$ 6.53M	$ 22.49M	$ 9.65M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 2.93M	$ 2.93M	$ 2.91M	$ 332.03K
Net Income From Continuing And Discontinued Operation	$ -2.54M	$ -2.54M	$ -667.74K	$ -315.55K
Normalized Income	$ -1.78M	$ -1.78M	$ -2.37M	$ -315.18K
Interest Expense	-	-	-	-
EBIT	$ -2.44M	$ -2.44M	$ -2.91M	$ -332.03K
EBITDA	$ -2.44M	$ -2.44M	$ -2.91M	$ -332.03K

Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing